Literature DB >> 35039660

Surgical management of primary severe hypospadias in children: an update focusing on penile curvature.

Marco Castagnetti1,2, Alaa El-Ghoneimi3.   

Abstract

Over the past two decades, assessment and treatment of associated curvature has emerged as a major issue in treating patients with proximal hypospadias. However, the cut-off for defining a curvature as clinically significant is still unclear, as not all patients are bothered by the same degree of curvature and, although the need for a method to assess the curvature objectively has been emphasized, no standard method yet exists. Curvature is multifactorial. The same degree of curvature can be due to any possible combination of skin and/or subcutaneous dartos tethering, a short urethral plate and an intrinsic corpora disproportion. Different strategies can be used to treat curvature, depending on the underlying cause, surgeon preferences, and the goals of the repair. In the past 10 years, use of urethral plate transection and ventral lengthening procedures has increased, although the lack of long-term follow-up data on ventral lengthening procedures suggests that the use of such procedures should be selective. Furthermore, straightening manoeuvres are influenced by the technique used for subsequent urethroplasty and, in turn, may influence the success rate of the urethroplasty. This Review provides a comprehensive overview of the major developments from the past 10 years in the management of severe proximal hypospadias in children.
© 2022. Springer Nature Limited.

Entities:  

Mesh:

Year:  2022        PMID: 35039660     DOI: 10.1038/s41585-021-00555-0

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


  54 in total

Review 1.  Surgical management of primary severe hypospadias in children: systematic 20-year review.

Authors:  Marco Castagnetti; Alaa El-Ghoneimi
Journal:  J Urol       Date:  2010-08-19       Impact factor: 7.450

2.  Assessing quality of life of patients with hypospadias: A systematic review of validated patient-reported outcome instruments.

Authors:  K J Sullivan; Z Hunter; V Andrioli; L Guerra; M Leonard; A Klassen; M A Keays
Journal:  J Pediatr Urol       Date:  2016-12-05       Impact factor: 1.830

3.  Staged Tubularized Autograft Repair for Primary Proximal Hypospadias with 30-Degree or Greater Ventral Curvature.

Authors:  Warren Snodgrass; Nicol Bush
Journal:  J Urol       Date:  2017-04-09       Impact factor: 7.450

4.  A farewell to chordee.

Authors:  Warren Snodgrass
Journal:  J Urol       Date:  2007-07-16       Impact factor: 7.450

5.  Hypospadias dilemmas: a round table.

Authors:  Warren Snodgrass; Antonio Macedo; Piet Hoebeke; Pierre D E Mouriquand
Journal:  J Pediatr Urol       Date:  2011-01-14       Impact factor: 1.830

Review 6.  Functional, cosmetic and psychosexual results in adult men who underwent hypospadias correction in childhood.

Authors:  S P Rynja; T P V M de Jong; J L H R Bosch; L M O de Kort
Journal:  J Pediatr Urol       Date:  2011-03-22       Impact factor: 1.830

7.  Congenital penile pathology is associated with abnormal development of the dartos muscle: a prospective study of primary penile surgery at a tertiary referral center.

Authors:  A-F Spinoit; C Van Praet; L-A Groen; E Van Laecke; M Praet; P Hoebeke
Journal:  J Urol       Date:  2014-10-23       Impact factor: 7.450

8.  Trends in hypospadias surgery: results of a worldwide survey.

Authors:  Alexander Springer; Wilfried Krois; Ernst Horcher
Journal:  Eur Urol       Date:  2011-08-22       Impact factor: 20.096

Review 9.  Current challenges with proximal hypospadias: We have a long way to go.

Authors:  Edward M Gong; Earl Y Cheng
Journal:  J Pediatr Urol       Date:  2017-04-21       Impact factor: 1.830

10.  Objective and subjective sexual outcomes in adult patients after hypospadias repair performed in childhood.

Authors:  Boris Chertin; Aladin Natsheh; Itzhak Ben-Zion; Dan Prat; Stanislav Kocherov; Amicur Farkas; Ofer Z Shenfeld
Journal:  J Urol       Date:  2013-01-08       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.